{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:20:09Z","timestamp":1778624409147,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02316-7","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:02:44Z","timestamp":1655416964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Hypoxia-Sensitive Drug Delivery System Constructed by Nitroimidazole and its Application in the Treatment of Hepatocellular Carcinoma"],"prefix":"10.1208","volume":"23","author":[{"given":"Tingting","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kequan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuwei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"2316_CR1","doi-asserted-by":"publisher","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;157. https:\/\/doi.org\/10.1186\/s12943-019-1089-9.","DOI":"10.1186\/s12943-019-1089-9"},{"key":"2316_CR2","doi-asserted-by":"publisher","first-page":"11386","DOI":"10.1021\/acsanm.1c01907","volume":"11","author":"R Afshari","year":"2021","unstructured":"Afshari R, Akhavan O, Hamblin MR, Varma RS. Review of oxygenation with nanobubbles: possible treatment for hypoxic COVID-19 patients. ACS Appl Nano Mater. 2021;11:11386\u2013412. https:\/\/doi.org\/10.1021\/acsanm.1c01907.","journal-title":"ACS Appl Nano Mater"},{"key":"2316_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2019.12.041","volume":"319","author":"R Kumari","year":"2020","unstructured":"Kumari R, Sunil D, Ningthoujam RS. Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: an up-to-date review. J Control Release. 2020;319:135\u201356. https:\/\/doi.org\/10.1016\/j.jconrel.2019.12.041.","journal-title":"J Control Release"},{"key":"2316_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352:175\u201380. https:\/\/doi.org\/10.1126\/science.aaf4405.","journal-title":"Science"},{"key":"2316_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/djx160","volume":"110","author":"A Salem","year":"2018","unstructured":"Salem A, Asselin M-C, Reymen B, Jackson A, Lambin P, West CML, O\u2019Connor JPB, Faivre-Finn C. Targeting hypoxia to improve non\u2013small cell lung cancer outcome. J Natl Cancer Inst. 2018;110:14\u201330. https:\/\/doi.org\/10.1093\/jnci\/djx160.","journal-title":"J Natl Cancer Inst"},{"key":"2316_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100814","volume":"9","author":"HS Peng","year":"2014","unstructured":"Peng HS, Liao MB, Zhang MY, Xie Y, Xu L, Zhang YJ, Zheng XF, Wang HY, Chen YF. Synergistic inhibitory effect of hyperbaric oxygen combined with sorafenib on hepatoma cells. PLoS ONE. 2014;9:e100814. https:\/\/doi.org\/10.1371\/journal.pone.0100814.","journal-title":"PLoS ONE"},{"key":"2316_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","volume":"33","author":"GL Semenza","year":"2012","unstructured":"Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012;33:207\u201314. https:\/\/doi.org\/10.1016\/j.tips.2012.01.005.","journal-title":"Trends Pharmacol Sci"},{"key":"2316_CR8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.apsb.2020.01.004","volume":"10","author":"Y Sun","year":"2020","unstructured":"Sun Y, Zhao D, Wang G, Wang Y, Cao L, Sun J, Jiang Q, He Z. Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development. Acta Pharm Sin B. 2020;10:1382\u201396. https:\/\/doi.org\/10.1016\/j.apsb.2020.01.004.","journal-title":"Acta Pharm Sin B"},{"key":"2316_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","volume":"9","author":"MC Wallace","year":"2015","unstructured":"Wallace MC, Preen D, Jeffrey GP, Adams LA. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroent. 2015;9:765\u201379. https:\/\/doi.org\/10.1586\/17474124.2015.1028363.","journal-title":"Expert Rev Gastroent"},{"key":"2316_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5582\/bst.2013.v7.5.250","volume":"7","author":"Song","year":"2013","unstructured":"Song. Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines. BioScience Trends. 2013;7:250\u20132. https:\/\/doi.org\/10.5582\/bst.2013.v7.5.250.","journal-title":"BioScience Trends"},{"key":"2316_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.21037\/tgh.2018.09.06","volume":"3","author":"S Zheng","year":"2018","unstructured":"Zheng S, Xie Q, Cheng J. Salvage liver transplant for hepatocellular carcinoma: rescues and benefits. Transl Gastroenterol Hepatol. 2018;3:65. https:\/\/doi.org\/10.21037\/tgh.2018.09.06.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"2316_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/cas.13191","volume":"108","author":"Y Tong","year":"2017","unstructured":"Tong Y, Yang H, Xu X, Ruan J, Liang M, Wu J, Luo B. Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion. Cancer Sci. 2017;108:753\u201362. https:\/\/doi.org\/10.1111\/cas.13191.","journal-title":"Cancer Sci"},{"key":"2316_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrgastro.2012.199","volume":"10","author":"A Villanueva","year":"2013","unstructured":"Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol. 2013;10:34\u201342. https:\/\/doi.org\/10.1038\/nrgastro.2012.199.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2316_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/ajg.2015.80","volume":"110","author":"A Facciorusso","year":"2015","unstructured":"Facciorusso A, Muscatiello N, Di Leo A, Barone M. Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial? Am J Gastroenterol. 2015;110:770\u20131. https:\/\/doi.org\/10.1038\/ajg.2015.80.","journal-title":"Am J Gastroenterol"},{"key":"2316_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174153","volume":"12","author":"Y Haga","year":"2017","unstructured":"Haga Y, Kanda T, Nakamura M, Nakamoto S, Sasaki R, Takahashi K, Wu S, Yokosuka O. Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines. PLoS ONE. 2017;12:e0174153. https:\/\/doi.org\/10.1371\/journal.pone.0174153.","journal-title":"PLoS ONE"},{"issue":"3","key":"2316_CR16","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1021\/acssuschemeng.8b06586","volume":"7","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zong Y, Yang Z, Luo M, Li G, Yingsa W, Cao Y, Xiao M, Kong T, He J, Liu X, Lei J. ACS Sustain Chem Eng. 2019;7(3):3614\u201323. https:\/\/doi.org\/10.1021\/acssuschemeng.8b06586.","journal-title":"ACS Sustain Chem Eng"},{"key":"2316_CR17","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1002\/jbm.a.36758","volume":"107A","author":"N Koirala","year":"2019","unstructured":"Koirala N, Das D, Fayazzadeh E, Sen S, McClain A, Puskas JE, Drazba JA, Mclennan G. Folic acid conjugated polymeric drug delivery vehicle for targeted cancer detection in hepatocellular carcinoma. J Biomed Mater Res. 2019;107A:2522\u201335. https:\/\/doi.org\/10.1002\/jbm.a.36758.","journal-title":"J Biomed Mater Res"},{"key":"2316_CR18","doi-asserted-by":"publisher","first-page":"9174","DOI":"10.1038\/s41598-017-09525-2","volume":"7","author":"D Yang","year":"2017","unstructured":"Yang D, Tian HY, Zang TN, Li M, Zhou Y, Zhang JF. Hypoxia imaging in cells and tumor tissues using a highly selective fluorescent nitroreductase probe. Sci Rep. 2017;7:9174. https:\/\/doi.org\/10.1038\/s41598-017-09525-2.","journal-title":"Sci Rep"},{"key":"2316_CR19","doi-asserted-by":"publisher","first-page":"120927","DOI":"10.1016\/j.biomaterials.2021.120927","volume":"275","author":"F Yu","year":"2021","unstructured":"Yu F, Shang X, Zhu Y, Lou H, Liu Y, Meng T, Hong Y, Yuan H, Hu F. Self-preparation system using glucose oxidase-inspired nitroreductase amplification for cascade-responsive drug release and multidrug resistance reversion. Biomaterials. 2021;275:120927. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120927.","journal-title":"Biomaterials"},{"key":"2316_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3139\/113.110633","volume":"56","author":"P Hol\u00ednkov\u00e1","year":"2019","unstructured":"Hol\u00ednkov\u00e1 P, Peka\u0159 M. Fluorescence study of aggregation behaviour of cationic surfactant carbethopendecinium bromide and its comparison with cetyltrimethylammonium bromide. Tenside Surfactant Deterg. 2019;56:300\u20135. https:\/\/doi.org\/10.3139\/113.110633.","journal-title":"Tenside Surfactant Deterg"},{"key":"2316_CR21","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.1021\/am501390v","volume":"6","author":"T Liu","year":"2014","unstructured":"Liu T, Yang C-T, Dieguez L, Denman JA, Thierry B. Robust and flexible fabrication of chemical micropatterns for tumor spheroid preparation. ACS Appl Mater Interfaces. 2014;6:10162\u201371. https:\/\/doi.org\/10.1021\/am501390v.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2316_CR22","doi-asserted-by":"publisher","first-page":"1801486","DOI":"10.1002\/adhm.201801486","volume":"8","author":"X Liu","year":"2019","unstructured":"Liu X, Wang C, Ma H, Yu F, Hu F, Yuan H. Water-responsive hybrid nanoparticles codelivering ICG and DOX effectively treat breast cancer via hyperthermia-aided DOX functionality and drug penetration. Adv Healthc Mater. 2019;8:1801486. https:\/\/doi.org\/10.1002\/adhm.201801486.","journal-title":"Adv Healthc Mater"},{"key":"2316_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4110\/in.2013.13.4.141","volume":"13","author":"E-H Kim","year":"2013","unstructured":"Kim E-H, Won J-H, Hwang I, Yu J-W. Cobalt chloride-induced hypoxia ameliorates NLRP3-mediated caspase-1 activation in mixed glial cultures. Immune Netw. 2013;13:141\u20137. https:\/\/doi.org\/10.4110\/in.2013.13.4.141.","journal-title":"Immune Netw"},{"key":"2316_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5213\/inj.1938190.095","volume":"23","author":"S-Y Yoo","year":"2019","unstructured":"Yoo S-Y, Yoo J-Y, Kim H-B, Baik T-K, Lee J-H, Woo R-S. Neuregulin-1 protects neuronal cells against damage due to CoCl2-induced hypoxia by suppressing hypoxia-inducible factor-1\u03b1 and P53 in SH-SY5Y cells. Int Neurourol J. 2019;23:111\u20138. https:\/\/doi.org\/10.5213\/inj.1938190.095.","journal-title":"Int Neurourol J"},{"key":"2316_CR25","doi-asserted-by":"publisher","first-page":"1(2021)","DOI":"10.1186\/s40360-020-00461-y","volume":"22","author":"D Li","year":"2021","unstructured":"Li D, Liu S, Zhu J, Shen L, Zhang Qy, Zhu H. Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular\u2002carcinoma. BMC Pharmacol Toxicol. 2021;22:1(2021). https:\/\/doi.org\/10.1186\/s40360-020-00461-y.","journal-title":"BMC Pharmacol Toxicol"},{"key":"2316_CR26","doi-asserted-by":"publisher","first-page":"102288","DOI":"10.1016\/j.jddst.2020.102288","volume":"61","author":"F Maghsoudinia","year":"2021","unstructured":"Maghsoudinia F, Tavakoli MB, Samani RK, Motaghi H, Hejazi SH, Mehrgardi MA. Bevacizumab and folic acid dual-targeted gadolinium-carbon dots for fluorescence\/magnetic resonance imaging of hepatocellular carcinoma. J Drug Deliv Sci Technol. 2021;61:102288. https:\/\/doi.org\/10.1016\/j.jddst.2020.102288.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2316_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.4149\/neo_2017_509","volume":"64","author":"F Li","year":"2017","unstructured":"Li F, Wang F, Wu J. Sorafenib inhibits growth of hepatoma with hypoxia and hypoxia-driven angiogenesis in nude mice. Neoplasma. 2017;64:718\u201324. https:\/\/doi.org\/10.4149\/neo_2017_509.","journal-title":"Neoplasma"},{"key":"2316_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.drup.2014.10.002","volume":"17","author":"YG Assaraf","year":"2014","unstructured":"Assaraf YG, Leamon CP, Reddy JA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat. 2014;17:89\u201395. https:\/\/doi.org\/10.1016\/j.drup.2014.10.002.","journal-title":"Drug Resist Updat"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02316-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T16:05:27Z","timestamp":1666109127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02316-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["2316"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02316-7","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"167"}}